← Open Payments lookup

DEBRA DAVIS: Open Payments

NPI 1417117953 · FOLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,005 in 102 payments from 17 companies in 2025. Trend: 2023 $20,086 · 2024 $2,551 · 2025 $2,005

Food & beverage: $2,005
CompanyPaymentsAmount
ABBVIE INC.32$571
Lilly USA, LLC14$258
AstraZeneca Pharmaceuticals LP10$256
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$190
GlaxoSmithKline, LLC.3$152
Novo Nordisk Inc13$148
Bayer Healthcare Pharmaceuticals Inc.3$79
Axsome Therapeutics, Inc.2$52
Exact Sciences Corporation3$52
Amgen Inc.3$42

Products named: VRAYLAR, QULIPTA, MOUNJARO, CAPLYTA, FARXIGA, Ozempic, AREXVY, AIRSUPRA.

Industry payments across AL — which companies pay providers there.